Antimicrobial-resistant (AMR) “superbugs” contribute to more than 4.5 million deaths globally per year and threaten to make ...

Armata Pharma reports positive data from phase 1b/2a diSArm study of intravenously administered AP-SA02 to treat S. aureus bacteremia: Los Angeles Tuesday, May 20, 2025, 17:00 Hrs ...

aureus ("MRSA"). All subjects infected with MRSA ... aureus bacteria, independent of antibiotic resistance patterns and site of infection." "These data, including the favorable safety profile ...

A peripheral IV is started for hydration and intravenous antibiotic treatment with either vancomycin or clindamycin is initiated for SSTIs with significant cellulitis. Our institution’s antibiogram ...

After incubation, the growth pattern ... (HAIs), caused in most instances by antibiotic-resistant microbes, is another major driver for bacterial disease diagnosis. Methicillin-resistant ...

Researchers describe a fundamental mechanism of antibiotic resistance. What happens in a bacterium that is resistant to the ...

The impact of antimicrobial resistance (AMR) is not a future threat: it is a present and escalating crisis that demands ...

Diabetes is a global epidemic that affects an estimated 828 million people worldwide.1 In the past decade, diabetes has emerged as a major challenge to health systems globally, and about 42% of people ...

Four tests that could allow people with urinary tract infections to receive the correct course of antibiotics more ... to the rise of antimicrobial resistance (AMR). In a draft early value ...